Purchase Order VA77016P1485
Award Date 8/10/16
Potential Completion Date 8/17/16
Potential Value $456K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wayne, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $452,280.00 and a performance period ending on February 2, 2017. This contract is not set-aside and is awarded under Emergent Devices' existing $11.8 million multiple-award Federal Supply Schedule...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs for NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $130,256.64 and is a Firm Fixed Price Delivery Order. It is not a set-aside contract. Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds multiple...
- This federal contract award to Emergent Devices, Inc. is for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract was awarded by the U.S. Department of Veterans Affairs, with a ceiling value of $455,898.24. Emergent Devices is a for-profit pharmaceutical manufacturer that specializes in supplying medical countermeasures to the federal government, including various naloxone formulations to address the ongoing opioid crisis. This contract...
- The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
- This is a $686,400.00 Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical goods. The contract is part of the VA's Federal Supply Schedule 65 IB for Pharmaceuticals and Drugs, which allows the agency to purchase naloxone nasal spray and other hematology-related products from Emergent Devices through August 2028. Emergent Devices has also received sub-awards from state health...
- The Department of Veterans Affairs Veterans Health Administration awarded a $672,672.00 Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of the opioid overdose reversal medication naloxone. This order is under Emergent Devices' existing Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. The contract has no set-aside designation. Emergent Devices has previously received sub-awards from...
- The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
- The Department of Veterans Affairs Veterans Health Administration awarded a $934,410.48 firm fixed-price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule, which allows Veterans Integrated Service Network 12 to procure pharmaceuticals through a streamlined vehicle. Emergent Devices, a for-profit...
- This federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, is for the provision of pharmaceuticals, specifically NARCAN nasal spray and other naloxone products, to various U.S. government agencies. The $226,140.00 Firm Fixed Price delivery order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 and has a completion date of January 13, 2017. Emergent Devices holds two significant federal contract vehicles - an $11.8...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray. The contract is a firm-fixed price order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a potential value of $904,465.44. The contract does not have a set-aside designation. Naloxone is a medication that rapidly reverses opioid overdoses and is used to...